Vakona Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.8M

  • Investors
  • 6

Vakona General Information

Description

Developer of acne drugs designed to provide novel, efficient and antibiotic-free treatment for acne. The company develops drugs for acne, based on a protein from a skin bacterium that is normally found on our skin and can be used by applying skin cream by acne patients, enabling an effective treatment option for people suffering from acne problems.

Contact Information

Website
www.vakona.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeaa
  • Sweden
+46
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • Tvistevägen 48 C
  • 907 36 Umeaa
  • Sweden
+46

Vakona Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vakona Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 31-Oct-2023 $2.8M Completed Product Development
2. Early Stage VC 29-Mar-2023 Completed Startup
1. Early Stage VC 09-Nov-2021 $1.74M $1.74M Completed Startup
To view Vakona’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vakona Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Vakona Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220072108-A1 New compositions and methods for the treatment of acne vulgaris Pending 21-Mar-2019
EP-3942030-A1 New compositions and methods for the treatment of acne vulgaris Pending 21-Mar-2019
CA-3133047-A1 New compositions and methods for the treatment of acne vulgaris Pending 21-Mar-2019
AU-2020241178-A1 New compositions and methods for the treatment of acne vulgaris Pending 21-Mar-2019
EP-3942030-A4 New compositions and methods for the treatment of acne vulgaris Pending 21-Mar-2019 A61K38/465
To view Vakona’s complete patent history, request access »

Vakona Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Execa Allocation Venture Capital Minority
Almi Invest Venture Capital Minority
Partnerinvest Norr Venture Capital Minority
Phase2Phase Biopharma Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Vakona FAQs

  • When was Vakona founded?

    Vakona was founded in 2020.

  • Where is Vakona headquartered?

    Vakona is headquartered in Umeaa, Sweden.

  • What industry is Vakona in?

    Vakona’s primary industry is Pharmaceuticals.

  • Is Vakona a private or public company?

    Vakona is a Private company.

  • What is the current valuation of Vakona?

    The current valuation of Vakona is .

  • What is Vakona’s current revenue?

    The current revenue for Vakona is .

  • How much funding has Vakona raised over time?

    Vakona has raised $5.86M.

  • Who are Vakona’s investors?

    , Execa Allocation, Almi Invest, Partnerinvest Norr, and Phase2Phase Biopharma are 5 of 6 investors who have invested in Vakona.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »